Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
7.39
+0.19 (2.60%)
Feb 21, 2025, 3:22 PM EST - Market open
Company Description
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders.
The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.
It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Firefly Neuroscience, Inc.
| Country | Canada |
| Founded | 2006 |
| Industry | Software - Application |
| Sector | Technology |
| CEO | Greg Lipschitz |
Contact Details
Address: 150 King St W, Suite 722 Toronto, ON M5H 1J9 Canada | |
| Phone | 888-237-6412 |
| Website | fireflyneuro.com |
Stock Details
| Ticker Symbol | AIFF |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000803578 |
| CUSIP Number | 317970101 |
| ISIN Number | US3179701012 |
| Employer ID | 54-1167364 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Gil Issachar | Chief Technology Officer |
| Dr. Jason DuBraski | Vice President of Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 20, 2025 | SCHEDULE 13G | Filing |
| Feb 14, 2025 | 8-K | Current Report |
| Feb 13, 2025 | EFFECT | Notice of Effectiveness |
| Feb 7, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Feb 5, 2025 | EFFECT | Notice of Effectiveness |
| Jan 29, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jan 21, 2025 | DEF 14A | Other definitive proxy statements |
| Jan 13, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jan 8, 2025 | SCHEDULE 13G/A | Filing |
| Jan 8, 2025 | PRE 14A | Other preliminary proxy statements |